Compare Adaptive Biotechnologies Corp (ADPT) vs Aterian Inc (ATER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Aterian Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Aterian Inc trades at $0.48 (market cap $5.32M). The key difference: Adaptive Biotechnologies Corp is far larger — about 759.4× Aterian Inc's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Aterian Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | ATER | |
|---|---|---|
Market Cap | $4.04B | $5.32M |
Sector | Health | Consumer Cyclical |
52-Week High | $25.45 | $1.39 |
52-Week Low | $12.30 | $0.36 |
Enterprise Value | $4.10B | $5.90M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Aterian Inc
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →
